{"@context":{"obo_purl":"http://purl.obolibrary.org/obo/","rdf":"http://www.w3.org/1999/02/22-rdf-syntax-ns#","owl":"http://www.w3.org/2002/07/owl#","rdfs":"http://www.w3.org/2000/01/rdf-schema#","metadata_def":"http://data.bioontology.org/metadata/def/","oboinowl_gen":"http://www.geneontology.org/formats/oboInOwl#","metadata":"http://data.bioontology.org/metadata/"},"@graph":[{"@id":"obo_purl:CHEBI_38070","@type":"owl:Class","rdfs:subClassOf":{"@id":"obo_purl:CHEBI_35554"},"rdfs:label":"anti-arrhythmia drug","obo_purl:IAO_0000115":"A drug used for the treatment or prevention of cardiac arrhythmias. Anti-arrhythmia drugs may affect the polarisation-repolarisation phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibres.","metadata:def/prefLabel":"anti-arrhythmia drug","oboinowl_gen:hasRelatedSynonym":["anti-arrhythmia agent","antiarrhythmic agent"],"metadata:def/mappingLoom":"antiarrhythmiadrug","metadata:def/mappingSameURI":{"@id":"obo_purl:CHEBI_38070"},"metadata:prefixIRI":"obo1:CHEBI_38070"},{"@id":"obo_purl:CHEBI_32599","obo_purl:RO_0000087":{"@id":"obo_purl:CHEBI_38070"}}]}